Search Results - "Derigs, Hans G."

Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial by Brixner, Veronika, Bug, Gesine, Pohler, Petra, Krämer, Doris, Metzner, Bernd, Voss, Andreas, Casper, Jochen, Ritter, Ulrich, Klein, Stefan, Alakel, Nael, Peceny, Rudolf, Derigs, Hans G, Stegelmann, Frank, Wolf, Martin, Schrezenmeier, Hubert, Thiele, Thomas, Seifried, Erhard, Kapels, Hans-Hermann, Döscher, Andrea, Petershofen, Eduard K, Müller, Thomas H, Seltsam, Axel

“…Pathogen reduction (PR) technologies for blood components have been established to reduce the residual risk of known and emerging infectious agents. THERAFLEX…”
Get full text

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p by Neben, Kai, Lokhorst, Henk M., Jauch, Anna, Bertsch, Uta, Hielscher, Thomas, van der Holt, Bronno, Salwender, Hans, Blau, Igor W., Weisel, Katja, Pfreundschuh, Michael, Scheid, Christof, Dührsen, Ulrich, Lindemann, Walter, Schmidt-Wolf, Ingo G.H., Peter, Norma, Teschendorf, Christian, Martin, Hans, Haenel, Mathias, Derigs, Hans G., Raab, Marc S., Ho, Anthony D., van de Velde, Helgi, Hose, Dirk, Sonneveld, Pieter, Goldschmidt, Hartmut

“…In patients with multiple myeloma (MM), risk stratification by chromosomal abnormalities may enable a more rational selection of therapeutic approaches. In the…”
Get full text

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study by Hofheinz, Ralf-Dieter, Anchisi, Sandro, Grünberger, Birgit, Derigs, Hans G, Zahn, Mark-Oliver, Geffriaud-Ricouard, Christine, Gueldner, Max, Windemuth-Kieselbach, Christine, Pederiva, Stefanie, Bohanes, Pierre, Scholten, Felicitas, Piringer, Gudrun, Thaler, Josef, von Moos, Roger

“…Aflibercept plus FOLFIRI prolongs overall survival (OS) in patients with metastatic colorectal cancer after the failure of oxaliplatin-containing therapy…”
Get full text

Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation by Wölfel, Catherine, Lennerz, Volker, Lindemann, Eva, Hess, Georg, Derigs, Hans G., Huber, Christoph, Herr, Wolfgang, Wölfel, Thomas

“…We applied a cDNA expression screening procedure with cryopreserved non-clonal CD8+ T cell populations (Lennerz et al., Proc. Natl. Acad. Sci. USA 102:16013-8,…”
Get full text